Skip to content
Stay curious ↗

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Today/Immunology
Immunology · The big question

COVID vaccines reduce death risk in hip fracture surgeries

Vaccination is associated with reduced mortality rates after surgery for hip fractures in the setting of recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database.

PubMed2 min readAI-assisted summary
Editorial illustration for Vaccination is associated with reduced mortality rates after surgery for hip fractures in the setting of recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database.
Editorial illustration

Summary

Broken hips are serious medical emergencies, especially for older adults. When a patient needs surgery to fix a hip fracture, doctors must carefully manage their recovery. A new study looked at an added complication: what happens if the patient recently had COVID-19? Researchers found that for these patients, being fully vaccinated makes a crucial difference. In fact, patients who were unvaccinated or only partially vaccinated had a risk of death nearly four and a half times higher in the 90 days following their operation compared to fully vaccinated patients.

The timing of the surgery also plays a vital role. The researchers discovered that performing the hip operation closer to a COVID-19 infection carries greater dangers. Patients who had surgery just six weeks after their infection faced a 53 percent higher risk of death over the next 90 days compared to those who had a six-month buffer. Furthermore, having a recent COVID-19 infection increased the likelihood of a patient developing dangerous blood clots in their veins, a condition known medically as venous thromboembolism, by more than three times.

To uncover these trends, the research team analyzed records from 3,674 patients treated through the Kaiser Permanente Northern California health system between 2020 and 2022. Because the study simply observed existing medical records rather than setting up a controlled experiment, it cannot definitively prove that the vaccines directly caused the better survival rates. Additionally, since the data comes from a single geographic region, the findings might not perfectly reflect what happens in hospitals worldwide.

Why it matters.

Hip fractures already carry a high risk of complications, particularly for aging populations. This research provides surgeons and families with vital information for managing those vulnerabilities. It reveals a hidden, surgical benefit of keeping up with immunizations. Vaccines do not just prevent severe respiratory illness, but they also appear to help the body survive the intense physical stress of a major orthopedic operation.

Practically, these findings could change how hospitals plan post-infection care. If a patient recently had COVID-19, doctors might need to be extra vigilant about monitoring for blood clots. While fixing a broken hip is almost always an urgent necessity, understanding the severe dangers of operating soon after a viral infection can help medical teams better prepare for complications and ultimately save lives.

From the source

The story in numbers.

Patients included
3,674
Higher 90-day mortality risk in unvaccinated/partially vaccinated patients
4.49-fold
Higher postoperative VTE risk with recent infection
3.14-fold
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Immunology

HPV and measles vaccines save the most lives per dose, study finds

Researchers recently set out to answer a crucial global health question: which vaccines save the most lives per dose? To find out, they analyzed vaccination programs for 14 preventable diseases across 117 low-income and middle-income countries. These nations are supported by Gavi, a global health alliance that helps fund and distribute vaccines. By looking at these programs, the researchers calculated an impact ratio for each disease, which simply measures how many deaths are averted for every 1,000 vaccinations given. Two vaccines stood out clearly from the rest. The vaccine against human papillomavirus, commonly known as HPV, generated the highest impact, preventing just over 11 deaths for every 1,000 vaccinations. The measles vaccine followed closely behind, averting about six deaths per 1,000 doses. For the other vaccines included in the study, the life-saving impact varied significantly based on the specific geographical region and the type of immunization program being run. However, the researchers are careful to point out some early-stage limitations. Because this is a computer modeling study, it relies on complex mathematical formulas rather than direct real-world counting. The researchers noted that there are built-in uncertainties in the data and the models. Because of these mathematical variables, the estimated impact ratios for many of the vaccines overlap, meaning it is difficult to create a perfect, rigid ranking for every single shot.

PubMed2 min read
Immunology

Unlocking a Surprising Immune Defense Against Leprosy and TB

Our immune system relies on special molecules to act as display windows, showing fragments of invading bugs to disease-fighting T cells. For years, scientists believed a specific display molecule called CD1a had a very narrow job. They thought it only presented fatty, lipid-based molecules from invaders. However, while studying the immune response to the bacteria that cause leprosy, researchers stumbled upon a surprising discovery. They found that CD1a can actually display standard protein fragments, known as peptides, effectively rewriting the rulebook on how this molecule functions. The researchers pinpointed two specific bacterial proteins, known as LppX and Ag85A, that trigger this newly discovered process. When the bacteria are broken down into small, 12-part pieces, these protein fragments bind to the CD1a molecule. Once displayed, they strongly activate CD4 T cells, which are vital immune defenders. In response, these T cells multiply and release protective, antimicrobial chemicals to help fight off the infection. To see how this plays out in humans, the scientists looked at samples from people with leprosy. They discovered that patients undergoing intense immune flare ups, known as reversal reactions, had a much higher number of these specific T cells compared to healthy donors or patients with a more severe, uncontrolled form of the disease.

bioRxiv2 min read
Immunology

Shingles Vaccine Highly Effective for Autoimmune Patients

Patients with inflammatory rheumatic diseases, such as lupus, have immune systems that mistakenly attack their own bodies. Because they often take medications that suppress their immunity to manage these conditions, they are at a much higher risk of developing shingles. Shingles, or herpes zoster, is a painful skin rash caused by the reactivation of the chickenpox virus. Fortunately, researchers have found that a modern two-dose shot called the recombinant zoster vaccine is highly effective at preventing this condition. Real-world data shows the vaccine reduces the chance of a shingles relapse by about 95 percent in these vulnerable patients. A major concern for anyone with an autoimmune condition is whether a vaccine might accidentally trigger a "flare," causing their underlying disease symptoms to worsen. Reassuringly, controlled clinical trials indicate that the short-term risk of a flare after getting the shingles vaccine is generally no different than receiving a placebo. However, researchers are still paying close attention to real-world safety reports. A broad safety analysis of 920 autoimmune patients found that 8.5 percent experienced a disease flare after vaccination, representing a threefold increase in the odds of such events being reported. Patients with systemic lupus erythematosus appear to face a notably higher risk for these post-vaccination flares. Because of this, researchers emphasize that doctors should closely monitor these specific patients in the weeks following their shots. The crucial takeaway is that the risk of a temporary flare should prompt careful observation and patient counseling, rather than causing patients to avoid the vaccine entirely.

PubMed2 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗
COVID vaccines reduce death risk in hip fracture surgeries — Daily Strand